1 74 142 A GROUP-BASED YOGA THERAPY INTERVENTION FOR URINARY INCONTINENCE IN WOMEN: A PILOT RANDOMIZED TRIAL. OBJECTIVE: THE AIM OF THIS STUDY IS TO EXAMINE THE FEASIBILITY, EFFICACY, AND SAFETY OF A GROUP-BASED YOGA THERAPY INTERVENTION FOR MIDDLE-AGED AND OLDER WOMEN WITH URINARY INCONTINENCE. METHODS: WE CONDUCTED A PILOT RANDOMIZED TRIAL OF AMBULATORY WOMEN AGED 40 YEARS AND OLDER WITH STRESS, URGENCY, OR MIXED-TYPE INCONTINENCE. WOMEN WERE RANDOMIZED TO A 6-WEEK YOGA THERAPY PROGRAM (N = 10) CONSISTING OF TWICE WEEKLY GROUP CLASSES AND ONCE WEEKLY HOME PRACTICE OR A WAIT-LIST CONTROL GROUP (N = 9). ALL PARTICIPANTS ALSO RECEIVED WRITTEN PAMPHLETS ABOUT STANDARD BEHAVIORAL SELF-MANAGEMENT STRATEGIES FOR INCONTINENCE. CHANGES IN INCONTINENCE WERE ASSESSED WITH 7-DAY VOIDING DIARIES. RESULTS: THE MEAN (SD) AGE WAS 61.4 (8.2) YEARS, AND THE MEAN BASELINE FREQUENCY OF INCONTINENCE WAS 2.5 (1.3) EPISODES/D. AFTER 6 WEEKS, THE TOTAL INCONTINENCE FREQUENCY DECREASED BY 70% (1.8 [0.9] FEWER EPISODES/D) IN THE YOGA THERAPY VERSUS 13% (0.3 [1.7] FEWER EPISODES/D) IN THE CONTROL GROUP (P = 0.049). PARTICIPANTS IN THE YOGA THERAPY GROUP ALSO REPORTED AN AVERAGE OF 71% DECREASE IN STRESS INCONTINENCE FREQUENCY (0.7 [0.8] FEWER EPISODES/D) COMPARED WITH A 25% INCREASE IN CONTROLS (0.2 [1.1] MORE EPISODES/D) (P = 0.039). NO SIGNIFICANT DIFFERENCES IN REDUCTION IN URGENCY INCONTINENCE WERE DETECTED BETWEEN THE YOGA THERAPY VERSUS CONTROL GROUPS (1.0 [1.0] VERSUS 0.5 [0.5] FEWER EPISODES/D; P = 0.20). ALL WOMEN STARTING THE YOGA THERAPY PROGRAM COMPLETED AT LEAST 90% OF THE GROUP CLASSES AND PRACTICE SESSIONS. TWO PARTICIPANTS IN EACH GROUP REPORTED ADVERSE EVENTS UNRELATED TO THE INTERVENTION. CONCLUSIONS: FINDINGS PROVIDE PRELIMINARY EVIDENCE TO SUPPORT THE FEASIBILITY, EFFICACY, AND SAFETY OF A GROUP-BASED YOGA THERAPY INTERVENTION TO IMPROVE URINARY INCONTINENCE IN WOMEN. 2014 2 1133 55 EFFICACY OF YOGA FOR VASOMOTOR SYMPTOMS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: THIS STUDY AIMS TO DETERMINE THE EFFICACY OF YOGA IN ALLEVIATING VASOMOTOR SYMPTOMS (VMS) FREQUENCY AND BOTHER. METHODS: THIS STUDY WAS A THREE-BY-TWO FACTORIAL, RANDOMIZED CONTROLLED TRIAL. ELIGIBLE WOMEN WERE RANDOMIZED TO YOGA (N = 107), EXERCISE (N = 106), OR USUAL ACTIVITY (N = 142), AND WERE SIMULTANEOUSLY RANDOMIZED TO A DOUBLE-BLIND COMPARISON OF OMEGA-3 FATTY ACID (N = 177) OR PLACEBO (N = 178) CAPSULES. YOGA INTERVENTION CONSISTED OF 12 WEEKLY 90-MINUTE YOGA CLASSES WITH DAILY HOME PRACTICE. PRIMARY OUTCOMES WERE VMS FREQUENCY AND BOTHER ASSESSED BY DAILY DIARIES AT BASELINE, 6 WEEKS, AND 12 WEEKS. SECONDARY OUTCOMES INCLUDED INSOMNIA SYMPTOMS (INSOMNIA SEVERITY INDEX) AT BASELINE AND 12 WEEKS. RESULTS: AMONG 249 RANDOMIZED WOMEN, 237 (95%) COMPLETED 12-WEEK ASSESSMENTS. THE MEAN BASELINE VMS FREQUENCY WAS 7.4 PER DAY (95% CI, 6.6 TO 8.1) IN THE YOGA GROUP AND 8.0 PER DAY (95% CI, 7.3 TO 8.7) IN THE USUAL ACTIVITY GROUP. INTENT-TO-TREAT ANALYSES INCLUDED ALL PARTICIPANTS WITH RESPONSE DATA (N = 237). THERE WAS NO DIFFERENCE BETWEEN INTERVENTION GROUPS IN THE CHANGE IN VMS FREQUENCY FROM BASELINE TO 6 AND 12 WEEKS (MEAN DIFFERENCE [YOGA--USUAL ACTIVITY] FROM BASELINE AT 6 WK, -0.3 [95% CI, -1.1 TO 0.5]; MEAN DIFFERENCE [YOGA--USUAL ACTIVITY] FROM BASELINE AT 12 WK, -0.3 [95% CI, -1.2 TO 0.6]; P = 0.119 ACROSS BOTH TIME POINTS). RESULTS WERE SIMILAR FOR VMS BOTHER. AT WEEK 12, YOGA WAS ASSOCIATED WITH AN IMPROVEMENT IN INSOMNIA SYMPTOMS (MEAN DIFFERENCE [YOGA - USUAL ACTIVITY] IN THE CHANGE IN INSOMNIA SEVERITY INDEX, 1.3 [95% CI, -2.5 TO -0.1]; P = 0.007). CONCLUSIONS: AMONG HEALTHY WOMEN, 12 WEEKS OF YOGA CLASS PLUS HOME PRACTICE, COMPARED WITH USUAL ACTIVITY, DO NOT IMPROVE VMS FREQUENCY OR BOTHER BUT REDUCE INSOMNIA SYMPTOMS. 2014 3 111 41 A PILOT STUDY OF A HATHA YOGA TREATMENT FOR MENOPAUSAL SYMPTOMS. OBJECTIVE: TO ASSESS THE FEASIBILITY AND EFFICACY OF A YOGA TREATMENT FOR MENOPAUSAL SYMPTOMS. BOTH PHYSIOLOGIC AND SELF-REPORTED MEASURES OF HOT FLASHES WERE INCLUDED. METHODS: A PROSPECTIVE WITHIN-GROUP PILOT STUDY WAS CONDUCTED. PARTICIPANTS WERE 12 PERI- AND POST-MENOPAUSAL WOMEN EXPERIENCING AT LEAST 4 MENOPAUSAL HOT FLASHES PER DAY, AT LEAST 4 DAYS PER WEEK. ASSESSMENTS WERE ADMINISTERED BEFORE AND AFTER COMPLETION OF A 10-WEEK YOGA PROGRAM. PRE- AND POST-TREATMENT MEASURES INCLUDED: SEVERITY OF QUESTIONNAIRE-RATED MENOPAUSAL SYMPTOMS (WIKLUND SYMPTOM CHECK LIST), FREQUENCY, DURATION, AND SEVERITY OF HOT FLASHES (24-H AMBULATORY SKIN-CONDUCTANCE MONITORING; HOT-FLASH DIARY), INTERFERENCE OF HOT FLASHES WITH DAILY LIFE (HOT FLASH RELATED DAILY INTERFERENCE SCALE), AND SUBJECTIVE SLEEP QUALITY (PITTSBURGH SLEEP QUALITY INDEX). YOGA CLASSES INCLUDED BREATHING TECHNIQUES, POSTURES, AND RELAXATION POSES DESIGNED SPECIFICALLY FOR MENOPAUSAL SYMPTOMS. PARTICIPANTS WERE ASKED TO PRACTICE AT HOME 15 MIN EACH DAY IN ADDITION TO WEEKLY CLASSES. RESULTS: ELEVEN WOMEN COMPLETED THE STUDY AND ATTENDED A MEAN OF 7.45 (S.D. 1.63) CLASSES. SIGNIFICANT PRE- TO POST-TREATMENT IMPROVEMENTS WERE FOUND FOR SEVERITY OF QUESTIONNAIRE-RATED TOTAL MENOPAUSAL SYMPTOMS, HOT-FLASH DAILY INTERFERENCE; AND SLEEP EFFICIENCY, DISTURBANCES, AND QUALITY. NEITHER 24-H MONITORING NOR ACCOMPANYING DIARIES YIELDED SIGNIFICANT CHANGES IN HOT FLASHES. CONCLUSIONS: THE YOGA TREATMENT AND STUDY PROCEDURES WERE FEASIBLE FOR MIDLIFE WOMEN. IMPROVEMENT IN SYMPTOM PERCEPTIONS AND WELL BEING WARRANT FURTHER STUDY OF YOGA FOR MENOPAUSAL SYMPTOMS, WITH A LARGER NUMBER OF WOMEN AND INCLUDING A CONTROL GROUP. 2007 4 172 48 A RANDOMIZED CONTROLLED PILOT STUDY OF YOGA SKILLS TRAINING VERSUS AN ATTENTION CONTROL DELIVERED DURING CHEMOTHERAPY ADMINISTRATION. CONTEXT: IT IS IMPORTANT TO ADDRESS FATIGUE AND CO-OCCURRING SYMPTOMS DURING CHEMOTHERAPY TO PRESERVE QUALITY OF LIFE IN PATIENTS WITH GASTROINTESTINAL (GI) CANCER. OBJECTIVE: TO CONDUCT A RANDOMIZED CONTROLLED PILOT STUDY OF A YOGA SKILLS TRAINING (YST) INTERVENTION COMPARED TO AN ATTENTION CONTROL (AC) AMONG ADULTS DIAGNOSED WITH GI CANCER. METHODS: YST CONSISTED OF FOUR 30-MINUTE SESSIONS DELIVERED INDIVIDUALLY DURING CHEMOTHERAPY PLUS HOME PRACTICE. AC PROVIDED EMPATHIC ATTENTION PLUS HOME DIARIES. PATIENT-REPORTED (PROMIS T-SCORE) ASSESSMENTS OF FATIGUE, DEPRESSIVE SYMPTOMS, SLEEP DISTURBANCES, AND PSYCHOLOGICAL STRESS (PERCEIVED STRESS SCALE) WERE COLLECTED AT CHEMOTHERAPY VISITS: BASELINE, WEEK 8, WEEK 10 AND WEEK 14, AND ANALYZED USING A MIXED EFFECTS MODEL. INFLAMMATORY CYTOKINES WERE ASSESSED AT BASELINE AND WEEK 10. RESULTS: FORTY-FOUR OF 77 ADULTS APPROACHED AGREED TO PARTICIPATE (57%; YST N = 23; AC N = 21). PARTICIPANTS' MEAN AGE WAS 58 YEARS AND 48% WERE MEN. PARTICIPANTS RANDOMIZED TO YST REPORTED A LARGER DECLINE IN FATIGUE (-2.4 DIFFERENCE, D = 0.30) AND DEPRESSIVE SYMPTOMS (-2.5 DIFFERENCE, D = 0.30) THAN AC PARTICIPANTS FROM BASELINE TO WEEK 10 AND SLEEP DISTURBANCES AT WEEK 8 (-3.9 DIFFERENCE, D = 0.50). DIFFERENCES IN MAGNITUDE OF CHANGE IN SYMPTOMS WERE CONSISTENT WITH OR EXCEEDED A MINIMALLY IMPORTANT DIFFERENCE. PSYCHOLOGICAL STRESS DECREASED MORE IN THE AC AT WEEK 10 (D = 0.30). REDUCTIONS IN INFLAMMATORY CYTOKINES (IL-6, STNF R1) WERE LARGER IN THE YST GROUP THAN AC. CONCLUSION: YST SHOWED PROMISE FOR IMPROVING FATIGUE, DEPRESSIVE SYMPTOMS, SLEEP DISTURBANCES, AND INFLAMMATION. YST IS ALSO FEASIBLE AND REACHES PATIENTS UNDERREPRESENTED IN YOGA RESEARCH (I.E., GI CANCER, MEN), THUS WARRANTING FURTHER EXAMINATION. 2022 5 117 50 A PILOT STUDY OF GENTLE YOGA FOR SLEEP DISTURBANCE IN WOMEN WITH OSTEOARTHRITIS. OBJECTIVES: THE PURPOSE OF THIS STUDY WAS TO TEST THE FEASIBILITY AND ACCEPTABILITY OF A GENTLE YOGA INTERVENTION FOR SLEEP DISTURBANCE IN OLDER WOMEN WITH OSTEOARTHRITIS (OA) AND TO COLLECT INITIAL EFFICACY DATA ON THE INTERVENTION. METHODS: ALL PARTICIPANTS COMPLETED AN 8-WEEK YOGA PROGRAM THAT INCLUDED 75-MIN WEEKLY CLASSES AND 20 MIN OF NIGHTLY HOME PRACTICE. PARTICIPANTS WERE WOMEN WITH OA AND SYMPTOMS CONSISTENT WITH INSOMNIA. SYMPTOM QUESTIONNAIRES AND 1 WEEK OF WRIST ACTIGRAPHY AND SLEEP DIARIES WERE COMPLETED FOR 1 WEEK PRE- AND POST-INTERVENTION. RESULTS: FOURTEEN WOMEN WERE ENROLLED OF WHOM 13 COMPLETED THE STUDY (MEAN AGE 65.2 +/- 6.9 YEARS). PARTICIPANTS ATTENDED A MEAN OF 7.2 +/- 1.0 CLASSES AND PRACTICED AT HOME 5.83 +/- 1.66 NIGHTS/WEEK. THE INSOMNIA SEVERITY INDEX AND DIARY-REPORTED SLEEP ONSET LATENCY, SLEEP EFFICIENCY, AND NUMBER OF NIGHTS WITH INSOMNIA WERE SIGNIFICANTLY IMPROVED AT POST-INTERVENTION VERSUS PRE-INTERVENTION (P < .05). OTHER SLEEP OUTCOMES (PITTSBURGH SLEEP QUALITY INDEX, EPWORTH SLEEPINESS SCALE, DIARY-REPORTED TOTAL SLEEP TIME AND WAKE AFTER SLEEP ONSET) SHOWED IMPROVEMENT ON MEAN SCORES AT POST-INTERVENTION, BUT THESE WERE NOT STATISTICALLY SIGNIFICANT. ACTIGRAPHIC SLEEP OUTCOMES WERE NOT SIGNIFICANTLY CHANGED. CONCLUSIONS: THIS STUDY SUPPORTS THE FEASIBILITY AND ACCEPTABILITY OF A STANDARDIZED EVENING YOGA PRACTICE FOR MIDDLE-AGED TO OLDER WOMEN WITH OA. PRELIMINARY EFFICACY FINDINGS SUPPORT FURTHER RESEARCH ON THIS PROGRAM AS A POTENTIAL TREATMENT OPTION FOR OA-RELATED INSOMNIA. 2011 6 73 84 A GROUP-BASED YOGA PROGRAM FOR URINARY INCONTINENCE IN AMBULATORY WOMEN: FEASIBILITY, TOLERABILITY, AND CHANGE IN INCONTINENCE FREQUENCY OVER 3 MONTHS IN A SINGLE-CENTER RANDOMIZED TRIAL. BACKGROUND: BECAUSE OF THE LIMITATIONS OF EXISTING CLINICAL TREATMENTS FOR URINARY INCONTINENCE, MANY WOMEN WITH INCONTINENCE ARE INTERESTED IN COMPLEMENTARY STRATEGIES FOR MANAGING THEIR SYMPTOMS. YOGA HAS BEEN RECOMMENDED AS A BEHAVIORAL SELF-MANAGEMENT STRATEGY FOR INCONTINENCE, BUT EVIDENCE OF ITS FEASIBILITY, TOLERABILITY, AND EFFICACY IS LACKING. OBJECTIVE: TO EVALUATE THE FEASIBILITY AND TOLERABILITY OF A GROUP-BASED THERAPEUTIC YOGA PROGRAM FOR AMBULATORY MIDDLE-AGED AND OLDER WOMEN WITH INCONTINENCE, AND TO EXAMINE PRELIMINARY CHANGES IN INCONTINENCE FREQUENCY AS THE PRIMARY EFFICACY OUTCOME AFTER 3 MONTHS. MATERIALS AND METHODS: AMBULATORY WOMEN AGED 50 YEARS OR OLDER WHO REPORTED AT LEAST DAILY STRESS-, URGENCY-, OR MIXED-TYPE INCONTINENCE, WERE NOT ALREADY ENGAGED IN YOGA, AND WERE WILLING TO TEMPORARILY FORGO CLINICAL INCONTINENCE TREATMENTS WERE RECRUITED INTO A RANDOMIZED TRIAL IN THE SAN FRANCISCO BAY AREA. WOMEN WERE RANDOMLY ASSIGNED TO TAKE PART IN A PROGRAM OF TWICE-WEEKLY GROUP CLASSES AND ONCE-WEEKLY HOME PRACTICE FOCUSED ON IYENGAR-BASED YOGA TECHNIQUES SELECTED BY AN EXPERT YOGA PANEL (YOGA GROUP), OR A NONSPECIFIC MUSCLE STRETCHING AND STRENGTHENING PROGRAM DESIGNED TO PROVIDE A RIGOROUS TIME-AND-ATTENTION CONTROL (CONTROL GROUP) FOR 3 MONTHS. ALL PARTICIPANTS ALSO RECEIVED WRITTEN, EVIDENCE-BASED INFORMATION ABOUT BEHAVIORAL INCONTINENCE SELF-MANAGEMENT TECHNIQUES (PELVIC FLOOR EXERCISES, BLADDER TRAINING) CONSISTENT WITH USUAL FIRST-LINE CARE. INCONTINENCE FREQUENCY AND TYPE WERE ASSESSED BY VALIDATED VOIDING DIARIES. ANALYSIS OF COVARIANCE MODELS EXAMINED WITHIN- AND BETWEEN-GROUP CHANGES IN INCONTINENCE FREQUENCY AS THE PRIMARY EFFICACY OUTCOME OVER 3 MONTHS. RESULTS: OF THE 56 WOMEN RANDOMIZED (28 TO YOGA, 28 TO CONTROL), THE MEAN AGE WAS 65.4 (+/-8.1) YEARS (RANGE, 55-83 YEARS), THE MEAN BASELINE INCONTINENCE FREQUENCY WAS 3.5 (+/-2.0) EPISODES/D, AND 37 WOMEN (66%) HAD URGENCY-PREDOMINANT INCONTINENCE. A TOTAL OF 50 WOMEN COMPLETED THEIR ASSIGNED 3-MONTH INTERVENTION PROGRAM (89%), INCLUDING 27 IN THE YOGA AND 23 IN THE CONTROL GROUP (P = .19). OF THOSE, 24 (89%) IN THE YOGA AND 20 (87%) IN THE CONTROL GROUP ATTENDED AT LEAST 80% OF GROUP CLASSES. OVER 3 MONTHS, TOTAL INCONTINENCE FREQUENCY DECREASED BY AN AVERAGE OF 76% FROM BASELINE IN THE YOGA AND 56% IN THE CONTROL GROUP (P = .07 FOR BETWEEN-GROUP DIFFERENCE). STRESS INCONTINENCE FREQUENCY ALSO DECREASED BY AN AVERAGE OF 61% IN THE YOGA GROUP AND 35% IN CONTROLS (P = .045 FOR BETWEEN-GROUP DIFFERENCE), BUT CHANGES IN URGENCY INCONTINENCE FREQUENCY DID NOT DIFFER SIGNIFICANTLY BETWEEN GROUPS. A TOTAL OF 48 NONSERIOUS ADVERSE EVENTS WERE REPORTED, INCLUDING 23 IN THE YOGA AND 25 IN THE CONTROL GROUP, BUT NONE WERE DIRECTLY ATTRIBUTABLE TO YOGA OR CONTROL PROGRAM PRACTICE. CONCLUSION: FINDINGS DEMONSTRATE THE FEASIBILITY OF RECRUITING AND RETAINING INCONTINENT WOMEN ACROSS THE AGING SPECTRUM INTO A THERAPEUTIC YOGA PROGRAM, AND PROVIDE PRELIMINARY EVIDENCE OF REDUCTION IN TOTAL AND STRESS-TYPE INCONTINENCE FREQUENCY AFTER 3 MONTHS OF YOGA PRACTICE. WHEN TAUGHT WITH ATTENTION TO WOMEN'S CLINICAL NEEDS, YOGA MAY OFFER A POTENTIAL COMMUNITY-BASED BEHAVIORAL SELF-MANAGEMENT STRATEGY FOR INCONTINENCE TO ENHANCE CLINICAL TREATMENT, ALTHOUGH FUTURE RESEARCH SHOULD ASSESS WHETHER YOGA OFFERS UNIQUE BENEFITS FOR INCONTINENCE ABOVE AND BEYOND OTHER PHYSICAL ACTIVITY-BASED INTERVENTIONS. 2019 7 2323 44 TREATMENT OF CHRONIC PRIMARY SLEEP ONSET INSOMNIA WITH KUNDALINI YOGA: A RANDOMIZED CONTROLLED TRIAL WITH ACTIVE SLEEP HYGIENE COMPARISON. STUDY OBJECTIVES: PRIOR STUDIES HAVE SUGGESTED A BENEFIT OF YOGA FOR ALLEVIATING SLEEP DISTURBANCE; HOWEVER, MANY STUDIES HAVE HAD METHODOLOGICAL LIMITATIONS. THIS TRIAL STUDY AIMED TO EXTEND THAT LITERATURE BY INCLUDING AN ACTIVE SLEEP HYGIENE COMPARISON. METHODS: PARTICIPANTS AGED 25-59 YEARS WITH A PRIMARY COMPLAINT OF SLEEP ONSET INSOMNIA LASTING AT LEAST 6 MONTHS WERE BLOCK RANDOMIZED TO AN 8-WEEK KUNDALINI YOGA OR SLEEP HYGIENE INTERVENTION, BOTH CONSISTING OF INITIAL 60-MINUTE INSTRUCTION AND WEEKLY CHECK-INS. DAILY SLEEP DIARIES AND QUESTIONNAIRES WERE COLLECTED AT BASELINE, THROUGHOUT THE INTERVENTION, AND AT 6-MONTH FOLLOW-UP. DATA WERE ANALYZED USING LINEAR MIXED MODELS (N = 20 IN EACH GROUP). RESULTS: PARTICIPANT RATINGS OF THE INTERVENTIONS DID NOT SIGNIFICANTLY DIFFER. SLEEP HYGIENE IMPROVED SEVERAL DIARY AND QUESTIONNAIRE OUTCOMES, HOWEVER, YOGA RESULTED IN EVEN GREATER IMPROVEMENTS CORRESPONDING TO MEDIUM-TO-LARGE BETWEEN-GROUP EFFECT SIZES. TOTAL SLEEP TIME INCREASED PROGRESSIVELY ACROSS YOGA TREATMENT (D = 0.95, P = .002), CONCURRENT WITH INCREASED SLEEP EFFICIENCY (D = 1.36, P < .001) AND DECREASED SLEEP ONSET LATENCY (D = -1.16, P < .001), BUT WITHOUT CHANGES IN PRE-SLEEP AROUSAL (D =-0.30, P = .59). REMISSION RATES WERE ALSO HIGHER FOR YOGA COMPARED TO SLEEP HYGIENE, WITH >/= 80% OF YOGA PARTICIPANTS REPORTING AVERAGE SLEEP ONSET LATENCY < 30 MINUTES AND SLEEP EFFICIENCY > 80% AT 6-MONTH FOLLOW-UP. FOR OVER 50% OF YOGA PARTICIPANTS, THE INSOMNIA SEVERITY INDEX DECREASED BY AT LEAST 8 POINTS AT END OF TREATMENT AND FOLLOW-UP. CONCLUSIONS: YOGA, TAUGHT IN A SELF-CARE FRAMEWORK WITH MINIMAL INSTRUCTOR BURDEN, WAS ASSOCIATED WITH SELF-REPORTED IMPROVEMENTS ABOVE AND BEYOND AN ACTIVE SLEEP HYGIENE COMPARISON, SUSTAINED AT 6-MONTH FOLLOW-UP. FOLLOW-UP STUDIES ARE NEEDED TO ASSESS ACTIGRAPHY AND POLYSOMNOGRAPHY OUTCOMES, AS WELL AS POSSIBLE MECHANISMS OF CHANGE. CLINICAL TRIAL REGISTRATION: REGISTRY: CLINICALTRIALS.GOV; NAME: YOGA AS A TREATMENT FOR INSOMNIA; URL: HTTPS://CLINICALTRIALS.GOV/CT2/SHOW/NCT00033865; IDENTIFIER: NCT00033865. CITATION: KHALSA SBS, GOLDSTEIN MR. TREATMENT OF CHRONIC PRIMARY SLEEP ONSET INSOMNIA WITH KUNDALINI YOGA: A RANDOMIZED CONTROLLED TRIAL WITH ACTIVE SLEEP HYGIENE COMPARISON. J CLIN SLEEP MED. 2021;17(9):1841-1852. 2021 8 2273 43 THE ROLE OF YOGA IN THE MANAGEMENT OF BLADDER PAIN SYNDROME: A SINGLE-ARM PILOT STUDY. BACKGROUND: BLADDER PAIN SYNDROME (BPS) IS A DEVASTATING UROLOGIC CONDITION CHARACTERIZED BY IRRITATIVE BLADDER SYMPTOMS, PELVIC PAIN, AND DYSPAREUNIA. FIRST-LINE TREATMENT INCLUDES DIETARY, SELF-CARE AND BEHAVIORAL MODIFICATIONS. THE ANCIENT PRACTICE OF YOGA IS WELL SUITED TO TREAT BPS, BUT EVIDENCE IS LACKING ON ITS USE. AIMS: TO INVESTIGATE THE FEASIBILITY AND EFFICACY OF AN INTEGRATED YOGA MODULE ON BPS OUTCOMES AS MEASURED BY SELF-REPORTED QUESTIONNAIRES FROM BASELINE TO 3 MONTHS AFTER THERAPY. METHODS AND MATERIALS: THIS WAS A PROSPECTIVE SINGLE-ARM STUDY OF 8 PATIENTS WHO UNDERWENT 3 MONTHS OF INTEGRATED YOGA THERAPY. THE TREATMENT MODULE WAS PERFORMED 3 TO 4 TIMES WEEKLY AT HOME WITH 1 SESSION PERFORMED WEEKLY IN-OFFICE DURING THE FIRST MONTH TO ENSURE PROPER PERFORMANCE OF POSTURES. PATIENTS COMPLETED QUESTIONNAIRES (PELVIC PAIN AND URGENCY/FREQUENCY PATIENT SYMPTOM SCALE [PUF], PELVIC FLOOR IMPACT QUESTIONNAIRE - SHORT FORM 7 [PFIQ-7], SHORT FORM 36 QUESTIONNAIRE [SF-36], PITTSBURGH SLEEP QUALITY INDEX [PSQI]) AT BASELINE AND 3 MONTHS, INCLUDING PATIENT GLOBAL IMPRESSION OF IMPROVEMENT (PGI-I) AT THE 3-MONTH FOLLOW-UP VISIT. VOIDING DIARIES WERE ALSO REQUESTED AT BASELINE AND AT THE 3-MONTH ASSESSMENT. RESULTS: THERE WAS A TREND TOWARD IMPROVEMENT REGARDING PATIENTS' RESPONSES TO ALL QUESTIONNAIRES 3 MONTHS AFTER YOGA THERAPY, WITH THE ONLY STATISTICALLY SIGNIFICANT IMPROVEMENTS NOTED IN SOCIAL FUNCTION AND PAIN COMPONENTS OF THE SF-36. THERE WERE NO SIGNIFICANT CHANGES NOTED ON THE VOIDING DIARIES EXCEPT A NON-STATISTICALLY SIGNIFICANT TREND TOWARD INCREASED VOIDED VOLUMES. PATIENTS RATED THEIR EXPERIENCES WITH YOGA THERAPY POSITIVELY. CONCLUSIONS: YOGA THERAPY FOR BPS SHOWED EVIDENCE OF BENEFIT FOR IMPROVING BOTHERSOME BLADDER SYMPTOMS, PAIN AND VOIDING. A RANDOMIZED CONTROLLED TRIAL WILL FOLLOW TO INVESTIGATE THE EFFICACY OF THIS YOGA MODULE AGAINST A CONTROL GROUP. 2020 9 1749 50 PILOT STUDY OF INTEGRAL YOGA FOR MENOPAUSAL HOT FLASHES. OBJECTIVE: THIS STUDY AIMS TO OBTAIN PRELIMINARY DATA ON THE EFFICACY OF YOGA FOR REDUCING SELF-REPORTED MENOPAUSAL HOT FLASHES IN A RANDOMIZED STUDY INCLUDING AN ATTENTION CONTROL GROUP. METHODS: WE RANDOMIZED 54 LATE PERIMENOPAUSAL WOMEN (2-12 MO OF AMENORRHEA) AND POSTMENOPAUSAL WOMEN (>12 MO OF AMENORRHEA)--AGED 45 TO 58 YEARS AND WHO EXPERIENCED AT LEAST FOUR HOT FLASHES PER DAY, ON AVERAGE, FOR AT LEAST 4 WEEKS--TO ONE OF THREE GROUPS: YOGA, HEALTH AND WELLNESS EDUCATION (HW), AND WAIT LIST (WL). YOGA AND HW CLASSES CONSISTED OF WEEKLY 90-MINUTE CLASSES FOR 10 WEEKS. ALL WOMEN COMPLETED DAILY HOT FLASH DIARIES THROUGHOUT THE TRIAL (10 WK) TO TRACK THE FREQUENCY AND SEVERITY OF HOT FLASHES. THE MEAN HOT FLASH INDEX SCORE IS BASED ON THE NUMBER OF MILD, MODERATE, SEVERE, AND VERY SEVERE HOT FLASHES. RESULTS: HOT FLASH FREQUENCY DECLINED SIGNIFICANTLY ACROSS TIME FOR ALL THREE GROUPS, WITH THE STRONGEST DECLINE OCCURRING DURING THE FIRST WEEK. THERE WAS NO OVERALL SIGNIFICANT DIFFERENCE IN HOT FLASH FREQUENCY DECREASE OVER TIME BY TREATMENT GROUPS, BUT THE YOGA AND HW GROUPS FOLLOWED SIMILAR PATTERNS AND SHOWED GREATER DECREASES THAN THE WL GROUP. ON WEEK 10, WOMEN IN THE YOGA GROUP REPORTED AN APPROXIMATELY 66% DECREASE IN HOT FLASH FREQUENCY, WOMEN IN THE HW GROUP REPORTED A 63% DECREASE, AND WOMEN IN THE WL GROUP REPORTED A 36% DECREASE. THE HOT FLASH INDEX SHOWED A SIMILAR PATTERN. CONCLUSIONS: RESULTS SUGGEST THAT YOGA CAN SERVE AS A BEHAVIORAL OPTION FOR REDUCING HOT FLASHES BUT MAY NOT OFFER ANY ADVANTAGE OVER OTHER TYPES OF INTERVENTIONS. 2014 10 2321 33 TREATMENT OF CHRONIC INSOMNIA WITH YOGA: A PRELIMINARY STUDY WITH SLEEP-WAKE DIARIES. THERE IS GOOD EVIDENCE FOR COGNITIVE AND PHYSIOLOGICAL AROUSAL IN CHRONIC INSOMNIA. ACCORDINGLY, CLINICAL TRIAL STUDIES OF INSOMNIA TREATMENTS AIMED AT REDUCING AROUSAL, INCLUDING RELAXATION AND MEDITATION, HAVE REPORTED POSITIVE RESULTS. YOGA IS A MULTICOMPONENT PRACTICE THAT IS ALSO KNOWN TO BE EFFECTIVE IN REDUCING AROUSAL, ALTHOUGH IT HAS NOT BEEN WELL EVALUATED AS A TREATMENT FOR INSOMNIA. IN THIS PRELIMINARY STUDY, A SIMPLE DAILY YOGA TREATMENT WAS EVALUATED IN A CHRONIC INSOMNIA POPULATION CONSISTING OF SLEEP-ONSET AND/OR SLEEP-MAINTENANCE INSOMNIA AND PRIMARY OR SECONDARY INSOMNIA. PARTICIPANTS MAINTAINED SLEEP-WAKE DIARIES DURING A PRETREATMENT 2-WEEK BASELINE AND A SUBSEQUENT 8-WEEK INTERVENTION, IN WHICH THEY PRACTICED THE TREATMENT ON THEIR OWN FOLLOWING A SINGLE IN-PERSON TRAINING SESSION WITH SUBSEQUENT BRIEF IN-PERSON AND TELEPHONE FOLLOW-UPS. SLEEP EFFICIENCY (SE), TOTAL SLEEP TIME (TST), TOTAL WAKE TIME (TWT), SLEEP ONSET LATENCY (SOL), WAKE TIME AFTER SLEEP ONSET (WASO), NUMBER OF AWAKENINGS, AND SLEEP QUALITY MEASURES WERE DERIVED FROM SLEEP-WAKE DIARY ENTRIES AND WERE AVERAGED IN 2-WEEK INTERVALS. FOR 20 PARTICIPANTS COMPLETING THE PROTOCOL, STATISTICALLY SIGNIFICANT IMPROVEMENTS WERE OBSERVED IN SE, TST, TWT, SOL, AND WASO AT END-TREATMENT AS COMPARED WITH PRETREATMENT VALUES. 2004 11 1602 53 MENOPAUSAL QUALITY OF LIFE: RCT OF YOGA, EXERCISE, AND OMEGA-3 SUPPLEMENTS. OBJECTIVE: THE PURPOSE OF THIS STUDY WAS TO DETERMINE THE EFFICACY OF 3 NONHORMONAL THERAPIES FOR THE IMPROVEMENT OF MENOPAUSE-RELATED QUALITY OF LIFE IN WOMEN WITH VASOMOTOR SYMPTOMS. STUDY DESIGN: WE CONDUCTED A 12-WEEK 3 X 2 RANDOMIZED, CONTROLLED, FACTORIAL DESIGN TRIAL. PERI- AND POSTMENOPAUSAL WOMEN, 40-62 YEARS OLD, WERE ASSIGNED RANDOMLY TO YOGA (N = 107), EXERCISE (N = 106), OR USUAL ACTIVITY (N = 142) AND ALSO ASSIGNED RANDOMLY TO A DOUBLE-BLIND COMPARISON OF OMEGA-3 (N = 177) OR PLACEBO (N = 178) CAPSULES. WE PERFORMED THE FOLLOWING INTERVENTIONS: (1) WEEKLY 90-MINUTE YOGA CLASSES WITH DAILY AT-HOME PRACTICE, (2) INDIVIDUALIZED FACILITY-BASED AEROBIC EXERCISE TRAINING 3 TIMES/WEEK, AND (3) 0.615 G OMEGA-3 SUPPLEMENT, 3 TIMES/DAY. THE OUTCOMES WERE ASSESSED WITH THE FOLLOWING SCORES: MENOPAUSAL QUALITY OF LIFE QUESTIONNAIRE (MENQOL) TOTAL AND DOMAIN (VASOMOTOR SYMPTOMS, PSYCHOSOCIAL, PHYSICAL AND SEXUAL). RESULTS: AMONG 355 RANDOMLY ASSIGNED WOMEN WHO AVERAGE AGE WAS 54.7 YEARS, 338 WOMEN (95%) COMPLETED 12-WEEK ASSESSMENTS. MEAN BASELINE VASOMOTOR SYMPTOMS FREQUENCY WAS 7.6/DAY, AND THE MEAN BASELINE TOTAL MENQOL SCORE WAS 3.8 (RANGE, 1-8 FROM BETTER TO WORSE) WITH NO BETWEEN-GROUP DIFFERENCES. FOR YOGA COMPARED TO USUAL ACTIVITY, BASELINE TO 12-WEEK IMPROVEMENTS WERE SEEN FOR MENQOL TOTAL -0.3 (95% CONFIDENCE INTERVAL, -0.6 TO 0; P = .02), VASOMOTOR SYMPTOM DOMAIN (P = .02), AND SEXUALITY DOMAIN (P = .03) SCORES. FOR WOMEN WHO UNDERWENT EXERCISE AND OMEGA-3 THERAPY COMPARED WITH CONTROL SUBJECTS, IMPROVEMENTS IN BASELINE TO 12-WEEK TOTAL MENQOL SCORES WERE NOT OBSERVED. EXERCISE SHOWED BENEFIT IN THE MENQOL PHYSICAL DOMAIN SCORE AT 12 WEEKS (P = .02). CONCLUSION: ALL WOMEN BECOME MENOPAUSAL, AND MANY OF THEM SEEK MEDICAL ADVICE ON WAYS TO IMPROVE QUALITY OF LIFE; LITTLE EVIDENCE-BASED INFORMATION EXISTS. WE FOUND THAT, AMONG HEALTHY SEDENTARY MENOPAUSAL WOMEN, YOGA APPEARS TO IMPROVE MENOPAUSAL QUALITY OF LIFE; THE CLINICAL SIGNIFICANCE OF OUR FINDING IS UNCERTAIN BECAUSE OF THE MODEST EFFECT. 2014 12 1573 49 MANAGING KNEE OSTEOARTHRITIS WITH YOGA OR AEROBIC/STRENGTHENING EXERCISE PROGRAMS IN OLDER ADULTS: A PILOT RANDOMIZED CONTROLLED TRIAL. ALTHOUGH EXERCISE IS OFTEN RECOMMENDED FOR MANAGING OSTEOARTHRITIS (OA), LIMITED EVIDENCE-BASED EXERCISE OPTIONS ARE AVAILABLE FOR OLDER ADULTS WITH OA. THIS STUDY COMPARED THE EFFECTS OF HATHA YOGA (HY) AND AEROBIC/STRENGTHENING EXERCISES (ASE) ON KNEE OA. RANDOMIZED CONTROLLED TRIAL WITH THREE ARMS DESIGN WAS USED: HY, ASE, AND EDUCATION CONTROL. BOTH HY AND ASE GROUPS INVOLVED 8 WEEKLY 45-MIN GROUP CLASSES WITH 2-4 DAYS/WEEK HOME PRACTICE SESSIONS. CONTROL GROUP RECEIVED OA EDUCATION BROCHURES AND WEEKLY PHONE CALLS FROM STUDY STAFF. STANDARDIZED INSTRUMENTS WERE USED TO MEASURE OA SYMPTOMS, PHYSICAL FUNCTION, MOOD, SPIRITUAL HEALTH, FEAR OF FALLING, AND QUALITY OF LIFE AT BASELINE, 4 AND 8 WEEKS. HY/ASE ADHERENCES WERE ASSESSED WEEKLY USING CLASS ATTENDANCE RECORDS AND HOME PRACTICE VIDEO RECORDINGS. PRIMARY ANALYSIS OF THE DIFFERENCE IN THE CHANGE FROM BASELINE WAS BASED ON INTENT-TO-TREAT AND ADJUSTED FOR BASELINE VALUES. EIGHT-THREE ADULTS WITH SYMPTOMATIC KNEE OA COMPLETED THE STUDY (84% FEMALE; MEAN AGE 71.6 +/- 8.0 YEARS; MEAN BMI 29.0 +/- 7.0 KG/M(2)). RETENTION RATE WAS 82%. COMPARED TO THE ASE GROUP AT 8 WEEKS, PARTICIPANTS IN THE HY GROUP HAD A SIGNIFICANT IMPROVEMENT FROM BASELINE IN PERCEPTION OF OA SYMPTOMS (-9.6 [95% CI -15.3, -4]; P = .001), ANXIETY (-1.4 [95% CI -2.7, -0]; P = .04), AND FEAR OF FALLING (-4.6 [-7.5, -1.7]; P = .002). THERE WERE NO DIFFERENCES IN CLASS/HOME PRACTICE ADHERENCE BETWEEN HY AND ASE. THREE NON-SERIOUS ADVERSE EVENTS WERE REPORTED FROM THE ASE GROUP. BOTH HY AND ASE IMPROVED SYMPTOMS AND FUNCTION BUT HY MAY HAVE SUPERIOR BENEFITS FOR OLDER ADULTS WITH KNEE OA. TRIAL REGISTRATION THE FULL TRIAL PROTOCOL IS AVAILABLE AT CLINICALTRIALS.GOV (NCT02525341). 2017 13 1020 39 EFFECTS OF YOGA AND AEROBIC EXERCISE ON ACTIGRAPHIC SLEEP PARAMETERS IN MENOPAUSAL WOMEN WITH HOT FLASHES. STUDY OBJECTIVES: TO DETERMINE EFFECTS OF YOGA AND AEROBIC EXERCISE COMPARED WITH USUAL ACTIVITY ON OBJECTIVE ASSESSMENTS OF SLEEP IN MIDLIFE WOMEN. METHODS: SECONDARY ANALYSES OF A RANDOMIZED CONTROLLED TRIAL IN THE MENOPAUSE STRATEGIES: FINDING LASTING ANSWERS FOR SYMPTOMS AND HEALTH (MSFLASH) NETWORK CONDUCTED AMONG 186 LATE TRANSITION AND POSTMENOPAUSAL WOMEN AGED 40-62 Y WITH HOT FLASHES. WOMEN WERE RANDOMIZED TO 12 W OF YOGA, SUPERVISED AEROBIC EXERCISE, OR USUAL ACTIVITY. THE MEAN AND COEFFICIENT OF VARIATION (CV) OF CHANGE IN ACTIGRAPH SLEEP MEASURES FROM EACH INTERVENTION GROUP WERE COMPARED TO THE USUAL ACTIVITY GROUP USING LINEAR REGRESSION MODELS. RESULTS: BASELINE VALUES OF THE PRIMARY SLEEP MEASURES FOR THE ENTIRE SAMPLE WERE MEAN TOTAL SLEEP TIME (TST) = 407.5 +/- 56.7 MIN; MEAN WAKE AFTER SLEEP ONSET (WASO) = 54.6 +/- 21.8 MIN; MEAN CV FOR WASO = 37.7 +/- 18.7 AND MEAN CV FOR NUMBER OF LONG AWAKENINGS > 5 MIN = 81.5 +/- 46.9. CHANGES IN THE ACTIGRAPHIC SLEEP OUTCOMES FROM BASELINE TO WEEKS 11-12 WERE SMALL, AND NONE DIFFERED BETWEEN GROUPS. IN AN EXPLORATORY ANALYSIS, WOMEN WITH BASELINE PITTSBURGH SLEEP QUALITY INDEX HIGHER THAN 8 HAD SIGNIFICANTLY REDUCED TST-CV FOLLOWING YOGA COMPARED WITH USUAL ACTIVITY. CONCLUSIONS: THIS STUDY ADDS TO THE CURRENTLY SCANT LITERATURE ON OBJECTIVE SLEEP OUTCOMES FROM YOGA AND AEROBIC EXERCISE INTERVENTIONS FOR THIS POPULATION. ALTHOUGH SMALL EFFECTS ON SELF-REPORTED SLEEP QUALITY WERE PREVIOUSLY REPORTED, THE INTERVENTIONS HAD NO STATISTICALLY SIGNIFICANT EFFECTS ON ACTIGRAPH MEASURES, EXCEPT FOR POTENTIALLY IMPROVED SLEEP STABILITY WITH YOGA IN WOMEN WITH POOR SELF-REPORTED SLEEP QUALITY. 2017 14 41 44 A BRIEF YOGA INTERVENTION IMPLEMENTED DURING CHEMOTHERAPY: A RANDOMIZED CONTROLLED PILOT STUDY. OBJECTIVES: FATIGUE AND OTHER TREATMENT-RELATED SYMPTOMS (E.G., SLEEP DISTURBANCE) ARE CRITICAL TARGETS FOR IMPROVING QUALITY OF LIFE IN PATIENTS UNDERGOING CHEMOTHERAPY. YOGA MAY REDUCE THE BURDEN OF SUCH SYMPTOMS. THIS STUDY INVESTIGATED THE FEASIBILITY OF CONDUCTING A RANDOMIZED CONTROLLED STUDY OF A BRIEF YOGA INTERVENTION DURING CHEMOTHERAPY FOR COLORECTAL CANCER. DESIGN: WE RANDOMIZED ADULTS WITH COLORECTAL CANCER TO A BRIEF YOGA SKILLS TRAINING (YST) OR AN ATTENTION CONTROL (AC; EMPATHIC ATTENTION AND RECORDED EDUCATION). SETTING: THE INTERVENTIONS AND ASSESSMENTS WERE IMPLEMENTED INDIVIDUALLY IN THE CLINIC WHILE PATIENTS WERE IN THE CHAIR RECEIVING CHEMOTHERAPY. INTERVENTIONS: BOTH INTERVENTIONS CONSISTED OF THREE SESSIONS AND RECOMMENDED HOME PRACTICE. MAIN OUTCOME MEASURES: THE PRIMARY OUTCOME WAS FEASIBILITY (ACCRUAL, RETENTION, ADHERENCE, DATA COLLECTION). SELF-REPORTED OUTCOMES (I.E., FATIGUE, SLEEP DISTURBANCE, QUALITY OF LIFE) AND INFLAMMATORY BIOMARKERS WERE ALSO DESCRIBED TO INFORM FUTURE STUDIES. RESULTS: OF 52 PATIENTS INITIALLY IDENTIFIED, 28 WERE APPROACHED, AND 15 ENROLLED (AGE MEAN = 57.5 YEARS; 80% WHITE; 60% MALE). REASONS FOR DECLINING PARTICIPATION WERE: NOT INTERESTED (N = 6), DID NOT PERCEIVE A NEED (N = 2), AND OTHER (N = 5). TWO PARTICIPANTS WERE LOST TO FOLLOW-UP IN EACH GROUP DUE TO TREATMENT CHANGES. THUS, 75% OF PARTICIPANTS WERE RETAINED IN THE YST AND 71% IN THE AC ARM. PARTICIPANTS RETAINED IN THE STUDY ADHERED TO 97% OF THE IN-PERSON INTERVENTION SESSIONS AND COMPLETED ALL QUESTIONNAIRES. CONCLUSIONS: THIS STUDY DEMONSTRATED THE FEASIBILITY OF CONDUCTING A LARGER RANDOMIZED CONTROLLED TRIAL TO ASSESS YST AMONG PATIENTS RECEIVING CHEMOTHERAPY FOR COLORECTAL CANCER. DATA COLLECTED AND CHALLENGES ENCOUNTERED WILL INFORM FUTURE RESEARCH. 2016 15 1980 31 SLEEP MODERATES THE EFFECTS OF TIBETAN YOGA FOR WOMEN WITH BREAST CANCER UNDERGOING CHEMOTHERAPY. THIS STUDY EXAMINED SELF-REPORTED AND ACTIGRAPHY-ASSESSED SLEEP AND DEPRESSION AS MODERATORS OF THE EFFECT OF A TIBETAN YOGA INTERVENTION ON SLEEP AND DEPRESSION AMONG WOMEN UNDERGOING CHEMOTHERAPY FOR BREAST CANCER. THIS IS A SECONDARY ANALYSIS OF AN RCT EXAMINING A 4-SESSION TIBETAN YOGA PROGRAM (TYP; N = 74) VERSUS STRETCHING PROGRAM (STP; N = 68) OR USUAL CARE (UC; N = 85) ON SELF-REPORTED SLEEP (PITTSBURGH SLEEP QUALITY INDEX (PSQI), ACTIGRAPHY-ASSESSED SLEEP EFFICIENCY (SE)) AND DEPRESSION (CENTERS FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CES-D) FOR WOMEN UNDERGOING CHEMOTHERAPY FOR BREAST CANCER. DATA WERE COLLECTED AT BASELINE AND 1-WEEK AND 3-MONTH POST-INTERVENTION. BASELINE PSQI, ACTIGRAPHY-SE, AND CES-D WERE EXAMINED AS MODERATORS OF THE EFFECT OF GROUP ON PSQI, ACTIGRAPHY-SE, AND CES-D 1 WEEK AND 3 MONTHS AFTER TREATMENT. THERE WAS A SIGNIFICANT BASELINE ACTIGRAPHY-SE X GROUP EFFECT ON PSQI AT 1 WEEK (P < .001) AND 3 MONTHS (P = .002) AND ON CES-D AT 3 MONTHS (P = .049). SPECIFICALLY, THE NEGATIVE ASSOCIATION OF BASELINE ACTIGRAPHY-SE WITH SUBSEQUENT PSQI AND CES-D WAS BUFFERED FOR WOMEN IN THE TYP AND, TO A LESSER EXTENT IN STP, COMPARED TO THOSE IN THE UC. BASELINE PSQI AND CES-D WERE NOT SIGNIFICANT MODERATORS OF THE EFFECT OF GROUP ON ANY OUTCOME. BEHAVIORALLY ASSESSED SLEEP MAY BE A MORE ROBUST INDICATOR OF WHICH PATIENTS ARE MOST APPROPRIATE FOR A YOGA INTERVENTION THAN SELF-REPORTED SLEEP QUALITY. WOMEN WITH POOR SLEEP EFFICIENCY MAY DERIVE THE GREATEST BENEFIT IN TERMS OF SLEEP QUALITY AND MOOD FROM A YOGA INTERVENTION. 2022 16 312 49 AN EXPLORATORY RANDOMIZED CONTROLLED TRIAL OF A 12-WEEK YOGA VERSUS EDUCATIONAL FILM PROGRAM FOR THE MANAGEMENT OF RESTLESS LEGS SYNDROME: FEASIBILITY AND ACCEPTABILITY. OBJECTIVES: THE PRIMARY OBJECTIVES OF THIS PILOT TRIAL WERE TO ASSESS THE STUDY FEASIBILITY AND ACCEPTABILITY OF THE 12-WEEK YOGA AND EDUCATIONAL FILM PROGRAMS FOR THE MANAGEMENT OF RESTLESS LEGS SYNDROME (RLS) IN PREPARATION FOR A FUTURE RANDOMIZED CONTROLLED TRIAL (RCT). MATERIALS AND METHODS: THIS PILOT, PARALLEL-ARM, RANDOMIZED FEASIBILITY TRIAL WAS CONDUCTED AT TWO SITES, MORGANTOWN, WV AND COLUMBUS, OH. YOGA GROUP PARTICIPANTS ATTENDED 75-MIN IYENGAR YOGA CLASSES, TWICE WEEKLY FOR 4 WEEKS, THEN ONCE A WEEK FOR 8 WEEKS (16 TOTAL CLASSES), AND COMPLETED A 30-MIN HOMEWORK ROUTINE ON NONCLASS DAYS. EDUCATIONAL FILM GROUP PARTICIPANTS ATTENDED ONCE WEEKLY, 75-MIN CLASSES (12 TOTAL CLASSES), WHICH INCLUDED INFORMATION ON RLS AND OTHER SLEEP DISORDERS, RLS MANAGEMENT INCLUDING SLEEP HYGIENE PRACTICES, AND COMPLEMENTARY THERAPIES. FEASIBILITY AND ACCEPTABILITY OUTCOMES INCLUDED PROGRAM SATISFACTION AND RECRUITMENT, RETENTION, AND ADHERENCE RATES. IN ADDITION, PARTICIPANTS WERE ASKED THEIR PREFERENCES REGARDING THREE YOGA CLASS SCHEDULE SCENARIOS FOR A FUTURE STUDY. ATTENDANCE, YOGA, AND TREATMENT LOGS WERE COLLECTED WEEKLY. PROGRAM EVALUATION AND YOGA SCHEDULING QUESTIONNAIRES WERE COLLECTED AT WEEK 12. RESULTS: FORTY-ONE ADULTS WITH MODERATE TO SEVERE RLS WERE RANDOMIZED TO A 12-WEEK YOGA (N = 19) OR EDUCATIONAL FILM (N = 22) PROGRAM. THIRTY PARTICIPANTS (73%) COMPLETED THE PROGRAM. YOGA AND EDUCATION GROUP PARTICIPANTS ATTENDED AN AVERAGE OF 13.0 +/- 0.84 (81%) AND 10.3 +/- 0.3 CLASSES (85%), RESPECTIVELY. PARTICIPANTS FROM BOTH GROUPS INDICATED SATISFACTION WITH THE STUDY. ALL YOGA GROUP RESPONDENTS TO THE PROGRAM EVALUATION REPORTED THEY WOULD LIKELY (N = 6) OR VERY LIKELY (N = 7) CONTINUE YOGA PRACTICE; 86.7% OF EDUCATION GROUP RESPONDENTS (13 OF 15) INDICATED THAT THEY WERE LIKELY (N = 7) OR VERY LIKELY (N = 6) TO MAKE LASTING CHANGES BASED ON WHAT THEY HAD LEARNED. THE PREFERRED SCHEDULE FOR A FUTURE STUDY WAS A 16-WEEK STUDY WITH ONCE-WEEKLY YOGA CLASSES. CONCLUSIONS: THE FINDINGS OF THIS STUDY SUGGEST THAT A LARGER RCT COMPARING YOGA WITH AN EDUCATIONAL FILM GROUP FOR THE MANAGEMENT OF RLS IS FEASIBLE. TRIAL REGISTRATION: CLINICALTRIALS.GOV: NCT03570515; 02/01/2017. 2022 17 945 49 EFFECTS OF A 12-WEEK YOGA VERSUS A 12-WEEK EDUCATIONAL FILM INTERVENTION ON SYMPTOMS OF RESTLESS LEGS SYNDROME AND RELATED OUTCOMES: AN EXPLORATORY RANDOMIZED CONTROLLED TRIAL. STUDY OBJECTIVES: TO ASSESS THE EFFECTS OF A YOGA VERSUS EDUCATIONAL FILM (EF) PROGRAM ON RESTLESS LEGS SYNDROME (RLS) SYMPTOMS AND RELATED OUTCOMES IN ADULTS WITH RLS. METHODS: FORTY-ONE COMMUNITY-DWELLING, AMBULATORY NONPREGNANT ADULTS WITH MODERATE TO SEVERE RLS WERE RANDOMIZED TO A 12-WEEK YOGA (N = 19) OR EF PROGRAM (N = 22). IN ADDITION TO ATTENDING CLASSES, ALL PARTICIPANTS COMPLETED PRACTICE/TREATMENT LOGS. YOGA GROUP PARTICIPANTS WERE ASKED TO PRACTICE AT HOME 30 MINUTES PER DAY ON NONCLASS DAYS; EF PARTICIPANTS WERE INSTRUCTED TO RECORD ANY RLS TREATMENTS USED ON THEIR DAILY LOGS. CORE OUTCOMES ASSESSED PRETREATMENT AND POSTTREATMENT WERE RLS SYMPTOMS AND SYMPTOM SEVERITY (INTERNATIONAL RLS STUDY GROUP SCALE (IRLS) AND RLS ORDINAL SCALE), SLEEP QUALITY, MOOD, PERCEIVED STRESS, AND QUALITY OF LIFE (QOL). RESULTS: THIRTY ADULTS (13 YOGA, 17 EF), AGED 24 TO 73 (MEAN = 50.4 +/- 2.4 YEARS), COMPLETED THE 12-WEEK STUDY (78% FEMALE, 80.5% WHITE). POST-INTERVENTION, BOTH GROUPS SHOWED SIGNIFICANT IMPROVEMENT IN RLS SYMPTOMS AND SEVERITY, PERCEIVED STRESS, MOOD, AND QOL-MENTAL HEALTH (P